Caraway Therapeutics

Developer of natural cellular process of autophagy designed to open new target areas for drug discovery and development. The company's focus is on the autophagy system to improve the cellular process of clearing out unwanted proteins, organelles, and invading pathogens, it also arrests or reverses the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders, and neurodegeneration, enabling physicians to address unmet medical needs and to bring cures to patients with serious diseases.

Developer of non-invasive neurostimulation products designed to treat global health epidemics. The company's medical device technology offers transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus to allow for alterations in autonomic function, circadian regulation, and neuro-metabolic influence, enabling healthcare providers to provide drug-free options and improve patients' health outcomes.

Developer of a drug discovery platform designed to find new points of therapeutic intervention. The company's platform integrates RNA bioinformatics, chemical biology tools, chemical and biological assays, and RNA-directed medicinal chemistry, enabling physicians to treat a range of diseases including neurology, oncology, and rare genetic diseases.